Skip to main content
An official website of the United States government
Grant Details

Grant Number: 1R03CA170960-01A1 Interpret this number
Primary Investigator: Spink, David
Organization: Wadsworth Center
Project Title: Impact of Proximal Promoter Polymorphisms on Ahr Gene Expression in Human Lung
Fiscal Year: 2013


DESCRIPTION (provided by applicant): Since its discovery, the aryl hydrocarbon receptor (AhR) has been recognized as an integral component of the carcinogenic process initiated by smoke-born polycyclic aromatic hydrocarbons and other carcinogens that result from incomplete combustion. The AhR regulates the expression of a group of genes encoding phase I cytochrome P450 monooxygenases, phase II conjugating enzymes, and phase III metabolite transporters that metabolize and dispose of PAH carcinogens, while also causing a limited level of reactive, mutagenic intermediates. Despite the pivotal importance of the AhR in the carcinogenic process in human lung, the underlying molecular mechanisms controlling AhR expression are not well established. Recently, we identified four novel variants of a repeat polymorphism, including two previously unreported single-nucleotide polymorphisms within the repeat, of the human AHR gene and have established a new method for analyzing them. These novel polymorphisms occur in a critical control region of the proximal promoter that contains multiple binding sites for specificity protein transcription factors. Our central hypothesis is tha these newly characterized AHR gene polymorphisms affect the transcriptional regulation of AhR expression, which in turn leads to altered expression and inducibility of the carcinogen-bioactivating enzymes as well as phase II and III pathways of deactivation. The specific aims of our application are: 1) to determine the allelic frequencies of these novel polymorphisms of the AHR gene in normal tissue from lung cancer patients, and 2) to determine the roles of these novel polymorphisms in the transcriptional regulation of AhR expression. We will perform in vitro assays of transcription factor binding and AHR promoter activities in a lung tumor cell line and determine allelic expression of AhR mRNA in normal lung tissue from individuals heterozygous for these polymorphisms. These studies will determine the importance of novel polymorphisms in the AHR gene promoter on AhR expression and may ultimately lead to a clearer understanding of the genetic susceptibility to lung cancer.


Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer.
Authors: Spink B.C. , Bloom M.S. , Wu S. , Sell S. , Schneider E. , Ding X. , Spink D.C. .
Source: Toxicology and applied pharmacology, 2015-01-01; 282(1), p. 30-41.
EPub date: 2014-11-04.
PMID: 25447411
Related Citations

Back to Top